Analyst Ratings for Eagle Pharmaceuticals (EGRX)

EGRX Rating Summary

  |   Expand Research on EGRX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/9/2023 Piper Sandler David Amsellem Downgrade Underweight
(Neutral)		 17.00
(N/A)		 22.88
(2.14)		 -90.65% Details
4/7/2021 RBC Capital
» Updated 5/11/2021		 Daniel Busb New Coverage Outperform
(N/A)		 50.00
(52.00)		 41.28
(2.14)		 -94.82% Details